Citius Oncology (CTOR) Inventory Average (2024 - 2026)

Citius Oncology's Inventory Average history runs 3 years deep, the most recent figure standing at $22.6 million for Q1 2026.

• In Q1 2026, Inventory Average rose 52.42% year-over-year to $22.6 million; the TTM figure through Mar 2026 stood at $22.6 million (up 52.42% YoY), while the FY2025 annual figure was $15.3 million, changed N/A from the prior year.
• Inventory Average was $22.6 million for Q1 2026 at Citius Oncology, up from $22.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $22.6 million in Q1 2026 to a low of $11.3 million in Q4 2024.
• Historically, Inventory Average has averaged $17.9 million across 3 years, with a median of $18.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Inventory Average surged 98.35% in 2025, then surged 52.42% in 2026.
• A 3-year view of Inventory Average shows it stood at $11.3 million in 2024, then soared by 98.35% to $22.5 million in 2025, then rose by 0.83% to $22.6 million in 2026.
• The last three Inventory Average figures came in at $22.6 million (Q1 2026), $22.5 million (Q4 2025), and $19.7 million (Q3 2025), per Business Quant data.